Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 4:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Corneal Opacity
Interventions: Mitomycin-C, Fluorometholone 1% topical ocular steroid; Drug
Lead sponsor: United States Naval Medical Center, San Diego; Federal
Eligibility: 21 Years to 65 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Breast Cancer, Invasive Breast Cancer, Metastatic Breast Cancer, Breast Carcinoma, Metastatic Breast Carcinoma
Interventions: Outcomes4Me Mobile App; Device
Lead sponsor: Outcomes4Me; Industry
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol Use Disorder, Alcohol-related Liver Disease
Interventions: Connections App; Device
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Enrollment: 298 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 3
States / cities: Lansing, Michigan • Madison, Wisconsin

Conditions: Peripheral Neuropathy With Type 2 Diabetes
Interventions: Intraneural Facilitation Therapy Treatment, Standard Physical Therapy Treatment; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 45 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Malignant Neoplasm
Interventions: Telemedicine, Questionnaire Administration; Other
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Pain
Interventions: Cognitive Behavioral Therapy, Chronic Pain Self Management Program, Taper Only; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Schizophrenia, Bipolar 1 Disorder, Major Depressive Disorder
Interventions: Abilify MyCite - Digital Medicine System, Aripiprazole or other oral antipsychotics; Combination Product · Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 63 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 5
States / cities: Santa Rosa, California • Decatur, Georgia • Smyrna, Georgia + 2 more

Conditions: Superficial Basal Cell Carcinoma
Interventions: Tirbanibulin Ointment 1%; Drug
Lead sponsor: Austin Institute for Clinical Research; Network
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Pflugerville, Texas

Conditions: Painful Bladder Syndrome, Interstitial Cystitis
Interventions: standard acupuncture treatment, Control Sham/Minimal Acupuncture; Device
Lead sponsor: Loyola University; Other
Eligibility: 21 Years to 65 Years · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Postoperative Pain
Interventions: RADA16 hydrogel; Device
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 3 Years to 17 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Livingston, New Jersey • Newark, New Jersey

Conditions: Prostate Cancer
Interventions: Problem-Solving Therapy; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years and older
Enrollment: 338 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1997 – 2005
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Type 1 Diabetes
Interventions: Tandem t:slim X2 with Control-IQ Technology Pro, Standard Care (SC), Tandem t:slim X2 with Control-IQ Technology V1.5; Device
Lead sponsor: Marc Breton; Other
Eligibility: 24 Months to 71 Months
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Stanford, California • Aurora, Colorado • Charlottesville, Virginia

Conditions: Asthma Chronic
Interventions: Asthma SMART; Device
Lead sponsor: University of South Florida; Other
Eligibility: 12 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Behavioral Economics, Gifts, Financial, Point
Interventions: Neuroflow app: Mental health and wellbeing resources for adults; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Periodontal Inflammation
Interventions: Brushlink application, Water-flosser, Interproximal brush; Other
Lead sponsor: University of Nebraska; Other
Eligibility: 40 Years to 85 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Lincoln, Nebraska

Conditions: Type 2 Diabetes, Type 2 Diabetes (T2DM)
Interventions: Eroxon®, tadalafil; Device · Drug
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 40 Years · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Stroke, Acute
Interventions: Harmony SHR, Traditional Occupational Therapy; Device · Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 21 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obstructive Sleep Apnea, Atrial Fibrillation
Interventions: Smartphone application use; Other
Lead sponsor: Philips Clinical & Medical Affairs Global; Industry
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Sioux Falls, South Dakota

Conditions: Stuttering, Adult
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Kansas State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Manhattan, Kansas

Conditions: Obesity
Interventions: Active transcranial direct current stimulation (tDCS), Hypocaloric diet, Sham transcranial direct current stimulation (tDCS); Device · Other
Lead sponsor: University of Sao Paulo; Other
Eligibility: 20 Years to 40 Years · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Schizophrenia, Schizoaffective Disorder
Interventions: Cognitive Remediation, Computer Skills; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pelvic Pain, Pelvic Floor Dysfunction, Voiding Dysfunction
Interventions: Home Pelvic Floor Trainer; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 8 Years to 18 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Nicotine Addiction, Drug Addiction, Drug Dependence, Substance Use Disorder, Tobacco Dependence
Interventions: Mobile Smoking Cessation Solution; Device
Lead sponsor: Click Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 416 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New York, New York

Conditions: Epilepsy
Interventions: Acoustic 1Hz Stimulation, Sham Background Noise; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 60 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements

Feasibility of Integrating the Outcomes4Me Smartphone Navigation Application Into the Care Management of Breast Cancer Patients

Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease

A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy

Telehealth in Improving Quality of Life in Patients During Post Radiation Therapy Visits

Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction: The EMPOWER Study

A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder

Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults

Acupuncture for Female IC/PBSyndrome and Its Effect on the Urinary Microbiome: A Randomized Controlled Trial

Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children

Problem Solving Therapy for Prostate Cancer Spousal Caregivers

The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes

Feasibility of a Smartphone Application for Asthma Self-management

Investigating How Incentives Impact Engagement With an Online Mental Health Application (Neuroflow)

Effect of Smartphone Application on Reducing Localized Inflammation in Periodontal Maintenance Patients

PLEASURE (Pleasing Lovers, Efficacy, Arousal, Satisfaction, and Uptake Research on Eroxon)

Harmony Scapulohumeral Rhythm (SHR) Reliability and Efficacy Study

Effective Conversion of Individuals at Risk

Using Transcranial Magnetic Stimulation to Treat Stuttering

Noninvasive Neuromodulation of the Prefrontal Cortex in Subjects With Obesity

Remediation of Working Memory in Schizophrenia

HOme PElvic Floor Improvement Trainer Trial

Clinical Trial of Smoking Cessation Mobile Phone Program

Acoustic Stimulation for Seizure Suppression